NCT00110630

Smoking Treatment of Prisoners

Smoking Treatment of Prisoners: Project "STOP"

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 250 (actual)
• Sponsor: National Institute on Drug Abuse (NIDA) · NIH
• Sex: Female
• Age: 18 Years – 100 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine the efficacy of a 10-week smoking cessation therapy combined with NicoDerm CQ for smoking cessation among female prisoners.

Detailed description

This is a randomized controlled trial utilizing a wait-list control group to examine 10-week group therapy and nicotine replacement compared to wait-list for smoking cessation among female prisoners.

Conditions

• Tobacco Use Cessation
• Tobacco Use Disorder

Interventions

Type	Name	Description
BEHAVIORAL	10-week smoking cessation group therapy combined with NicoDerm CQ

Timeline

• Start date: 2005-06-01
• Primary completion: 2007-09-01
• Completion: 2007-09-01
• First posted: 2005-05-11
• Last updated: 2017-01-12

Locations

1 site across 1 country: United States